Cargando…

Exhaled Biomarkers in Idiopathic Pulmonary Fibrosis—A Six-Month Follow-up Study in Patients Treated with Pirfenidone

The mechanism of action of pirfenidone in idiopathic pulmonary fibrosis (IPF) has not been fully elucidated. To offer additional insight, we evaluated the change in the cytokine profile in exhaled breath condensate (EBC) following a six-month treatment with pirfenidone in patients with IPF. EBC conc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jaskiewicz, Kaja, Mycroft, Katarzyna, Maskey-Warzechowska, Marta, Paralusz, Karolina, Siemiez, Natalia, Nejman-Gryz, Patrycja, Barnas, Malgorzata, Krenke, Rafal, Gorska, Katarzyna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465603/ https://www.ncbi.nlm.nih.gov/pubmed/32764328 http://dx.doi.org/10.3390/jcm9082523

Ejemplares similares

Blood and Sputum Eosinophils of COPD Patients Are Differently Polarized than in Asthma
por: Mycroft, Katarzyna, et al.
Publicado: (2023)

The Role of Chitinases in Chronic Airway Inflammation Associated with Tobacco Smoke Exposure
por: Przysucha, Natalia, et al.
Publicado: (2022)

Is the composition of exhaled breath condensate a key to explain the course of COVID-19 in children?
por: Krejner-Bienias, Alicja, et al.
Publicado: (2020)

Periostin and Thymic Stromal Lymphopoietin—Potential Crosstalk in Obstructive Airway Diseases
por: Nejman-Gryz, Patrycja, et al.
Publicado: (2020)

Sputum interleukin-25 correlates with asthma severity: a preliminary study
por: Paplińska-Goryca, Magdalena, et al.
Publicado: (2018)

The Expressions of TSLP, IL-33, and IL-17A in Monocyte Derived Dendritic Cells from Asthma and COPD Patients are Related to Epithelial–Macrophage Interactions
por: Paplinska-Goryca, Magdalena, et al.
Publicado: (2020)

Phenotypic Variations of Mild-to-Moderate Obstructive Pulmonary Diseases According to Airway Inflammation and Clinical Features
por: Proboszcz, Małgorzata, et al.
Publicado: (2021)

Interactions of nasal epithelium with macrophages and dendritic cells variously alter urban PM-induced inflammation in healthy, asthma and COPD
por: Paplinska-Goryca, Magdalena, et al.
Publicado: (2021)

Serum Amyloid A in Stable Patients with Chronic Obstructive Pulmonary Disease Does Not Reflect the Clinical Course of the Disease
por: Maskey-Warzęchowska, Marta, et al.
Publicado: (2023)

Therapeutic decisions in a cohort of patients with idiopathic pulmonary fibrosis: a multicenter, prospective survey from Poland
por: Górska, Katarzyna, et al.
Publicado: (2022)

Blood eosinophils as a predictor of treatment response in adults with difficult-to-treat chronic cough
por: Rybka-Fraczek, Aleksandra, et al.
Publicado: (2021)

Inflammatory Phenotypes of Cough Variant Asthma as Response Predictors to Anti-Asthmatic Therapy
por: Rybka-Fraczek, Aleksandra, et al.
Publicado: (2022)

A multicentre retrospective observational study on Polish experience of pirfenidone therapy in patients with idiopathic pulmonary fibrosis: the PolExPIR study
por: Majewski, Sebastian, et al.
Publicado: (2020)

Pharmacological Inhibition of Chitotriosidase (CHIT1) as a Novel Therapeutic Approach for Sarcoidosis
por: Dymek, Barbara, et al.
Publicado: (2022)

Relationship between airway inflammation and remodeling in patients with asthma and chronic obstructive pulmonary disease
por: Górska, K, et al.
Publicado: (2009)

Metabolomic Analysis of Respiratory Epithelial Lining Fluid in Patients with Chronic Obstructive Pulmonary Disease—A Systematic Review
por: Pulik, Kaja, et al.
Publicado: (2023)

Chitinases and Chitinase-Like Proteins in Obstructive Lung Diseases – Current Concepts and Potential Applications
por: Przysucha, Natalia, et al.
Publicado: (2020)

Pleural Effusion in Meigs’ Syndrome—Transudate or Exudate?: Systematic Review of the Literature
por: Krenke, Rafal, et al.
Publicado: (2015)

Diagnostic utility of pleural fluid and serum markers in differentiation between malignant and non-malignant pleural effusions
por: Korczynski, P, et al.
Publicado: (2009)

Active screening for COPD among hospitalized smokers – a feasibility study
por: Mycroft, Katarzyna, et al.
Publicado: (2020)

Diagnostic Accuracy of Contrast-Enhanced Computed Tomography and Positron Emission Tomography With 18-FDG in Identifying Malignant Solitary Pulmonary Nodules
por: Dabrowska, M., et al.
Publicado: (2015)

Pirfenidone treatment of idiopathic pulmonary fibrosis
por: Gan, Ye, et al.
Publicado: (2011)

Pirfenidone for Idiopathic Pulmonary Fibrosis and Beyond
por: Aimo, Alberto, et al.
Publicado: (2022)

The role of pirfenidone in the treatment of idiopathic pulmonary fibrosis
por: Cottin, Vincent
Publicado: (2013)

Efficacy and safety of pirfenidone for idiopathic pulmonary fibrosis
por: Takeda, Yoshito, et al.
Publicado: (2014)

The expression of the eotaxins IL-6 and CXCL8 in human epithelial cells from various levels of the respiratory tract
por: Paplińska-Goryca, Magdalena, et al.
Publicado: (2013)

Chronic cough – assessment of treatment efficacy based on two questionnaires
por: Dąbrowska, Marta, et al.
Publicado: (2014)

Evaluation of patients’ satisfaction with bronchoscopy procedure
por: Karewicz, Aleksandra, et al.
Publicado: (2022)

Effect of pirfenidone on cough in patients with idiopathic pulmonary fibrosis
por: van Manen, Mirjam J.G., et al.
Publicado: (2017)

Effect of pirfenidone on breathlessness in patients with idiopathic pulmonary fibrosis
por: Glassberg, Marilyn K., et al.
Publicado: (2019)

Efficacy and Safety of Pirfenidone in Advanced Versus Non-Advanced Idiopathic Pulmonary Fibrosis: Post-Hoc Analysis of Six Clinical Studies
por: Behr, Jürgen, et al.
Publicado: (2023)

Pirfenidone treatment in idiopathic pulmonary fibrosis: A Saudi experience
por: Alhamad, Esam H.
Publicado: (2015)

Pirfenidone treatment in idiopathic pulmonary fibrosis: nationwide Danish results
por: Salih, Goran Nadir, et al.
Publicado: (2016)

Efficacy and adverse events of pirfenidone in treating idiopathic pulmonary fibrosis
por: Ren, Hui, et al.
Publicado: (2017)

Pirfenidone tablets in idiopathic pulmonary fibrosis: a profile of their use
por: Lyseng-Williamson, Katherine A.
Publicado: (2017)

Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis
por: Flaherty, Kevin R., et al.
Publicado: (2018)

Effect of pirfenidone in patients with more advanced idiopathic pulmonary fibrosis
por: Costabel, Ulrich, et al.
Publicado: (2019)

Pirfenidone-Induced Photosensitivity in a Patient with Idiopathic Pulmonary Fibrosis
por: Kim, Ho-Jin, et al.
Publicado: (2018)

Pirfenidone safety and adverse event management in idiopathic pulmonary fibrosis
por: Lancaster, Lisa H., et al.
Publicado: (2017)

Genetic variations in idiopathic pulmonary fibrosis and patient response to pirfenidone
por: Kubbara, Aahd, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rj0rm3h0r0ejlgqib6b12r271d